{"id":631260,"date":"2025-02-04T14:46:35","date_gmt":"2025-02-04T19:46:35","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=631260"},"modified":"2026-01-28T14:13:51","modified_gmt":"2026-01-28T19:13:51","slug":"farxiga-vs-jardiance","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/farxiga-vs-jardiance\/","title":{"rendered":"Farxiga vs. Jardiance: Key differences, uses, and side effects"},"content":{"rendered":"

Farxiga<\/span><\/a> and <\/span>Jardiance<\/span><\/a> are two brand-name oral medications approved by the U.S. Food and Drug Administration (FDA) to manage <\/span>Type 2 diabetes mellitus<\/span><\/a>. Both are <\/span>sodium-glucose cotransporter 2 (SGLT2) inhibitors<\/span><\/a>. Farxiga, manufactured by AstraZeneca, contains the active drug dapagliflozin, and Jardiance, manufactured by Boehringer Ingelheim Pharmaceuticals, contains the active drug empagliflozin. Both drugs facilitate blood glucose (sugar) control in Type 2 diabetes mellitus by increasing urinary glucose, eliminating more sugar from the body. Although both drugs work similarly for glycemic control, there are some differences. Continue reading to learn more about Farxiga and Jardiance.<\/span><\/p>\n

What are the main differences between Farxiga and Jardiance?<\/span><\/h2>\n

Although Farxiga and Jardiance are in the same drug class and have the same mechanism of action, they contain two different active ingredients and have important differences.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Main differences of Farxiga and Jardiance<\/h3>\n<\/th>\n<\/tr>\n<\/thead>\n

<\/td>\nFarxiga<\/b><\/td>\nJardiance<\/b><\/td>\n<\/tr>\n
Drug class<\/b><\/td>\nSGLT2 inhibitor<\/span><\/td>\nSGLT2 inhibitor<\/span><\/td>\n<\/tr>\n
Brand\/generic status<\/b><\/td>\nBrand and generic available<\/span><\/td>\nBrand only<\/span><\/td>\n<\/tr>\n
What is the generic name?<\/b><\/td>\nDapagliflozin<\/span><\/td>\nEmpagliflozin<\/span><\/td>\n<\/tr>\n
What form(s) does the drug come in?<\/b><\/td>\nOral tablet: 5 mg, 10 mg<\/span><\/td>\nOral tablet: 10 mg, 25 mg<\/span><\/td>\n<\/tr>\n
What is the standard dosage?<\/b><\/td>\n5 or 10 mg once daily, depending on the condition being treated<\/span><\/td>\n10 or 25 mg once daily\u00a0<\/span><\/td>\n<\/tr>\n
How long is the typical treatment?<\/b><\/td>\nLong-term<\/span><\/td>\nLong-term<\/span><\/td>\n<\/tr>\n
Who typically uses the medication?<\/b><\/td>\nAdults and children 10 years and older<\/span><\/td>\nAdults and children 10 years and older for Type 2 diabetes; adults only for all other uses<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Conditions treated by Farxiga and Jardiance<\/span><\/h2>\n

Farxiga (dapagliflozin) and Jardiance (empagliflozin) are both prescription drugs approved by the FDA to lower blood sugar levels in those with Type 2 diabetes mellitus. Each has additional specific uses as described below.<\/span><\/p>\n

Farxiga is additionally FDA approved to:<\/span><\/p>\n